Vital Specialized Biopharmaceutical Insights and Analytics
for Experts from Experts
BioTrends is the premier provider of analysis and data on the significant issues facing the biopharmaceutical industry.
Although there are many treatments available for RA, there is still a high unmet need for new treatments, especially for patients who are refractory to current therapies, such as TNF-alpha inhibitors, the most widely used biologic agents in RA.
By comparing what nephrologists report about patient care dynamics to actual treatment records in CKD-ND, gaps in intended care versus actual care are uncovered and patient segments become more clearly defined. This new report covers patient demographics, referral patterns, length of treatment, blood transfusion rates, hospitalization rates and common reasons for referral in the Chinese market.